View ValuationSunjin Beauty ScienceLtd 将来の成長Future 基準チェック /06現在、 Sunjin Beauty ScienceLtdの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長63.8%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesValuation Update With 7 Day Price Move • May 21Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩8,690, the stock trades at a trailing P/E ratio of 17.5x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 10% over the past three years.New Risk • Apr 20New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.9% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.4% net profit margin). Market cap is less than US$100m (₩123.7b market cap, or US$83.9m).New Risk • Mar 27New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 31% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.4% net profit margin). Market cap is less than US$100m (₩116.3b market cap, or US$77.0m).Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩8,300, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 29% over the past three years.お知らせ • Feb 24Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 26, 2026Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, geumcheon-gu, seoul South KoreaUpcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 28 April 2026. Payout ratio is a comfortable 8.9% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).分析記事 • Nov 21Sunjin Beauty ScienceLtd (KOSDAQ:086710) Strong Profits May Be Masking Some Underlying IssuesSunjin Beauty Science Co.Ltd's ( KOSDAQ:086710 ) stock didn't jump after it announced some healthy earnings. Our...Reported Earnings • Nov 16Third quarter 2025 earnings released: EPS: ₩101 (vs ₩92.00 in 3Q 2024)Third quarter 2025 results: EPS: ₩101. Revenue: ₩18.9b (up 3.4% from 3Q 2024). Net income: ₩808.3m (down 27% from 3Q 2024). Profit margin: 4.3% (down from 6.1% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in South Korea.Buy Or Sell Opportunity • Nov 14Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to ₩9,350. The fair value is estimated to be ₩11,755, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has declined by 11%. Revenue is forecast to grow by 20% in a year. Earnings are forecast to grow by 49% in the next year.分析記事 • Nov 10Sunjin Beauty ScienceLtd (KOSDAQ:086710) Has Affirmed Its Dividend Of ₩60.00Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) has announced that it will pay a dividend of ₩60.00 per share on the...Declared Dividend • Nov 08Dividend of ₩60.00 announcedDividend of ₩60.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 28th April 2026 Dividend yield will be 0.6%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 43% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 42% over the next year, which should provide support to the dividend and adequate earnings cover.お知らせ • Nov 07Sunjin Beauty Science Co.Ltd announces Annual dividend, payable on April 28, 2026Sunjin Beauty Science Co.Ltd announced Annual dividend of KRW 60.0000 per share payable on April 28, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.New Risk • Aug 01New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩134.2b (US$95.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Market cap is less than US$100m (₩134.2b market cap, or US$95.7m).分析記事 • May 22Sunjin Beauty ScienceLtd's (KOSDAQ:086710) Solid Profits Have Weak FundamentalsLast week's profit announcement from Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) was underwhelming for investors...New Risk • May 22New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 24% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change).分析記事 • May 19These 4 Measures Indicate That Sunjin Beauty ScienceLtd (KOSDAQ:086710) Is Using Debt ExtensivelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • May 03We Like These Underlying Return On Capital Trends At Sunjin Beauty ScienceLtd (KOSDAQ:086710)There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...Valuation Update With 7 Day Price Move • May 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩15,190, the stock trades at a trailing P/E ratio of 20x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 85% over the past three years.New Risk • Apr 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).分析記事 • Apr 17Earnings Tell The Story For Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) As Its Stock Soars 34%Despite an already strong run, Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) shares have been powering on, with a gain...Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₩13,350, the stock trades at a trailing P/E ratio of 17.6x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 53% over the past three years.分析記事 • Apr 09At ₩10,670, Is Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) Worth Looking At Closely?Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ), might not be a large cap stock, but it saw a double-digit share price...New Risk • Mar 28New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 20% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (₩138.4b market cap, or US$94.4m).分析記事 • Feb 21Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) Popularity With Investors Is ClearWith a price-to-earnings (or "P/E") ratio of 17.4x Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) may be sending...お知らせ • Feb 21Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 28, 2025Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 28, 2025, at 10:00 Tokyo Standard Time. Location: conference room, geumcheon-gu, seoul South KoreaUpcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 30 April 2025. Payout ratio is a comfortable 6.2% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).分析記事 • Dec 16Sunjin Beauty ScienceLtd (KOSDAQ:086710) Shareholders Will Want The ROCE Trajectory To ContinueWhat are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩9,740, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 7x in the Chemicals industry in South Korea. Total returns to shareholders of 45% over the past three years.Reported Earnings • Nov 20Third quarter 2024 earnings released: EPS: ₩92.00 (vs ₩13.00 in 3Q 2023)Third quarter 2024 results: EPS: ₩92.00 (up from ₩13.00 in 3Q 2023). Revenue: ₩18.2b (up 19% from 3Q 2023). Net income: ₩1.10b (up ₩943.2m from 3Q 2023). Profit margin: 6.1% (up from 1.1% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Nov 12Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩9,230, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years.分析記事 • Nov 04Sunjin Beauty ScienceLtd (KOSDAQ:086710) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to ₩10,750, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 4.1% over the past three years.分析記事 • Aug 04Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) 30% Cheaper Price Remains In Tune With EarningsThe Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) share price has softened a substantial 30% over the previous 30...Buy Or Sell Opportunity • Aug 02Now 22% undervaluedOver the last 90 days, the stock has risen 38% to ₩12,220. The fair value is estimated to be ₩15,613, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 48% in 2 years. Earnings are forecast to grow by 119% in the next 2 years.分析記事 • Jul 27Is Sunjin Beauty ScienceLtd (KOSDAQ:086710) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...分析記事 • Jul 04What Does Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) Share Price Indicate?Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ), might not be a large cap stock, but it received a lot of attention from...Valuation Update With 7 Day Price Move • Jul 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩17,470, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 73% over the past three years.Buy Or Sell Opportunity • Jul 01Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 122% to ₩17,860. The fair value is estimated to be ₩14,271, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 48% in 2 years. Earnings are forecast to grow by 119% in the next 2 years.分析記事 • Jun 19After Leaping 94% Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) Shares Are Not Flying Under The RadarSunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) shares have continued their recent momentum with a 94% gain in the last...Buy Or Sell Opportunity • Jun 18Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 174% to ₩21,250. The fair value is estimated to be ₩17,414, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 25% in a year. Earnings are forecast to grow by 439% in the next year.Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₩22,200, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 132% over the past three years.Buy Or Sell Opportunity • Jun 14Now 27% overvalued after recent price riseOver the last 90 days, the stock has risen 190% to ₩22,200. The fair value is estimated to be ₩17,446, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 25% in a year. Earnings are forecast to grow by 439% in the next year.分析記事 • Jun 06Sunjin Beauty ScienceLtd (KOSDAQ:086710) Shareholders Will Want The ROCE Trajectory To ContinueIf you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...New Risk • May 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Profit margins are more than 30% lower than last year (8.4% net profit margin).Valuation Update With 7 Day Price Move • May 29Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₩15,500, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.Reported Earnings • May 19First quarter 2024 earnings released: EPS: ₩271 (vs ₩225 in 1Q 2023)First quarter 2024 results: EPS: ₩271 (up from ₩225 in 1Q 2023). Revenue: ₩20.8b (up 2.0% from 1Q 2023). Net income: ₩3.25b (up 20% from 1Q 2023). Profit margin: 16% (up from 13% in 1Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • May 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩10,460, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 11% over the past three years.分析記事 • Apr 23Does Sunjin Beauty ScienceLtd (KOSDAQ:086710) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Upcoming Dividend • Dec 20Upcoming dividend of ₩20.00 per share at 0.2% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 24 April 2024. Payout ratio is a comfortable 1.2% but the company is not cash flow positive. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).New Risk • Nov 30New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 31% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (31% accrual ratio). Minor Risk Market cap is less than US$100m (₩91.6b market cap, or US$70.6m).Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩7,960, the stock trades at a trailing P/E ratio of 4.6x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 29% over the past year.Valuation Update With 7 Day Price Move • Jun 28Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩10,560, the stock trades at a trailing P/E ratio of 6.1x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 77% over the past year.Valuation Update With 7 Day Price Move • May 10Investor sentiment improves as stock rises 31%After last week's 31% share price gain to ₩8,520, the stock trades at a trailing P/E ratio of 5.2x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 17% over the past year.Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩6,950, the stock trades at a trailing P/E ratio of 4.3x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 11% over the past year.Upcoming Dividend • Dec 21Upcoming dividend of ₩10.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 26 April 2023. Payout ratio is a comfortable 6.6% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of South Korean dividend payers (3.2%). Lower than average of industry peers (2.4%).Valuation Update With 7 Day Price Move • Dec 13Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩7,250, the stock trades at a trailing P/E ratio of 47.2x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 4.1% over the past year.Valuation Update With 7 Day Price Move • Nov 11Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩6,410, the stock trades at a trailing P/E ratio of 43x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 13% over the past year.Valuation Update With 7 Day Price Move • Sep 27Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩5,210, the stock trades at a trailing P/E ratio of 34.9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 41% over the past year.Valuation Update With 7 Day Price Move • Jun 22Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩5,530, the stock trades at a trailing P/E ratio of 39.1x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 43% over the past year.Buying Opportunity • May 10Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 2.8%. The fair value is estimated to be ₩9,160, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.0% over the last year. Earnings per share has declined by 64%.Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩21,400, the stock trades at a trailing P/E ratio of 50.5x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 5.6% over the past year.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩14,850, the stock trades at a trailing P/E ratio of 35x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 44% over the past year.Buying Opportunity • Jan 21Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be ₩17,656, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last year. Earnings per share has declined by 32% over the last year. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Sunjin Beauty ScienceLtd は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測KOSDAQ:A086710 - アナリストの将来予測と過去の財務データ ( )KRW Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202580,7665,961-8,94610,463N/A9/30/202581,4998,060-16,2358,415N/A6/30/202580,8728,357-25,8334,322N/A3/31/202581,0668,690-19,5447,143N/A12/31/202479,3729,122-12,91211,149N/A9/30/202478,7747,693-8,33111,104N/A6/30/202475,8246,74957410,229N/A3/31/202473,0246,163-6,1854,600N/A12/31/202372,6225,613-10,3692,198N/A9/30/202372,34920,765-8,7604,839N/A6/30/202371,47021,159-5,5197,690N/A3/31/202368,43820,690-8,5656,580N/A12/31/202264,33219,632-6,39110,748N/A9/30/202259,5501,845-14,1908,380N/A6/30/202255,1251,815-17,9936,473N/A3/31/202251,9691,721-10,41211,603N/A12/31/202148,7031,190-13,3884,924N/A9/30/202146,5182,580-8,7794,832N/A6/30/202144,5981,267-2,5248,562N/A3/31/202145,2341,569-2,3816,432N/A12/31/202046,3922,6289148,457N/A9/30/202045,0502,5551,57310,575N/A6/30/202048,9033,900-4,1284,641N/A3/31/202048,4984,399-12,1274,043N/A12/31/201947,4034,075-19,5874,004N/A12/31/201846,3765,045N/A4,328N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: A086710の予測収益成長が 貯蓄率 ( 3.1% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: A086710の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: A086710の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: A086710の収益がKR市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: A086710の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: A086710の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 01:19終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sunjin Beauty Science Co.Ltd 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Valuation Update With 7 Day Price Move • May 21Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩8,690, the stock trades at a trailing P/E ratio of 17.5x. Average trailing P/E is 14x in the Chemicals industry in South Korea. Total returns to shareholders of 10% over the past three years.
New Risk • Apr 20New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.9% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.4% net profit margin). Market cap is less than US$100m (₩123.7b market cap, or US$83.9m).
New Risk • Mar 27New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 31% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.8x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (7.4% net profit margin). Market cap is less than US$100m (₩116.3b market cap, or US$77.0m).
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩8,300, the stock trades at a trailing P/E ratio of 12.4x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 29% over the past three years.
お知らせ • Feb 24Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 26, 2026Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 26, 2026, at 10:00 Tokyo Standard Time. Location: conference room, geumcheon-gu, seoul South Korea
Upcoming Dividend • Dec 22Upcoming dividend of ₩60.00 per shareEligible shareholders must have bought the stock before 29 December 2025. Payment date: 28 April 2026. Payout ratio is a comfortable 8.9% but the company is not cash flow positive. Trailing yield: 0.6%. Lower than top quartile of South Korean dividend payers (3.6%). Lower than average of industry peers (1.3%).
分析記事 • Nov 21Sunjin Beauty ScienceLtd (KOSDAQ:086710) Strong Profits May Be Masking Some Underlying IssuesSunjin Beauty Science Co.Ltd's ( KOSDAQ:086710 ) stock didn't jump after it announced some healthy earnings. Our...
Reported Earnings • Nov 16Third quarter 2025 earnings released: EPS: ₩101 (vs ₩92.00 in 3Q 2024)Third quarter 2025 results: EPS: ₩101. Revenue: ₩18.9b (up 3.4% from 3Q 2024). Net income: ₩808.3m (down 27% from 3Q 2024). Profit margin: 4.3% (down from 6.1% in 3Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 12% growth forecast for the Chemicals industry in South Korea.
Buy Or Sell Opportunity • Nov 14Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 16% to ₩9,350. The fair value is estimated to be ₩11,755, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 11% over the last 3 years. Earnings per share has declined by 11%. Revenue is forecast to grow by 20% in a year. Earnings are forecast to grow by 49% in the next year.
分析記事 • Nov 10Sunjin Beauty ScienceLtd (KOSDAQ:086710) Has Affirmed Its Dividend Of ₩60.00Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) has announced that it will pay a dividend of ₩60.00 per share on the...
Declared Dividend • Nov 08Dividend of ₩60.00 announcedDividend of ₩60.00 is the same as last year. Ex-date: 29th December 2025 Payment date: 28th April 2026 Dividend yield will be 0.6%, which is lower than the industry average of 1.7%. Sustainability & Growth Dividend is covered by earnings (9% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 43% per year over the past 5 years and payments have been stable during that time. EPS is expected to grow by 42% over the next year, which should provide support to the dividend and adequate earnings cover.
お知らせ • Nov 07Sunjin Beauty Science Co.Ltd announces Annual dividend, payable on April 28, 2026Sunjin Beauty Science Co.Ltd announced Annual dividend of KRW 60.0000 per share payable on April 28, 2026, ex-date on December 29, 2025 and record date on December 31, 2025.
New Risk • Aug 01New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩134.2b (US$95.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Market cap is less than US$100m (₩134.2b market cap, or US$95.7m).
分析記事 • May 22Sunjin Beauty ScienceLtd's (KOSDAQ:086710) Solid Profits Have Weak FundamentalsLast week's profit announcement from Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) was underwhelming for investors...
New Risk • May 22New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 24% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (12% operating cash flow to total debt). High level of non-cash earnings (24% accrual ratio). Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change).
分析記事 • May 19These 4 Measures Indicate That Sunjin Beauty ScienceLtd (KOSDAQ:086710) Is Using Debt ExtensivelyHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
分析記事 • May 03We Like These Underlying Return On Capital Trends At Sunjin Beauty ScienceLtd (KOSDAQ:086710)There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'll want to see a...
Valuation Update With 7 Day Price Move • May 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩15,190, the stock trades at a trailing P/E ratio of 20x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 85% over the past three years.
New Risk • Apr 22New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 9.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risk Share price has been volatile over the past 3 months (9.0% average weekly change).
分析記事 • Apr 17Earnings Tell The Story For Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) As Its Stock Soars 34%Despite an already strong run, Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) shares have been powering on, with a gain...
Valuation Update With 7 Day Price Move • Apr 14Investor sentiment improves as stock rises 19%After last week's 19% share price gain to ₩13,350, the stock trades at a trailing P/E ratio of 17.6x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 53% over the past three years.
分析記事 • Apr 09At ₩10,670, Is Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) Worth Looking At Closely?Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ), might not be a large cap stock, but it saw a double-digit share price...
New Risk • Mar 28New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 20% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (20% operating cash flow to total debt). Minor Risk Market cap is less than US$100m (₩138.4b market cap, or US$94.4m).
分析記事 • Feb 21Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) Popularity With Investors Is ClearWith a price-to-earnings (or "P/E") ratio of 17.4x Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) may be sending...
お知らせ • Feb 21Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 28, 2025Sunjin Beauty Science Co.Ltd, Annual General Meeting, Mar 28, 2025, at 10:00 Tokyo Standard Time. Location: conference room, geumcheon-gu, seoul South Korea
Upcoming Dividend • Dec 20Upcoming dividend of ₩40.00 per shareEligible shareholders must have bought the stock before 27 December 2024. Payment date: 30 April 2025. Payout ratio is a comfortable 6.2% but the company is not cash flow positive. Trailing yield: 0.4%. Lower than top quartile of South Korean dividend payers (3.9%). Lower than average of industry peers (2.2%).
分析記事 • Dec 16Sunjin Beauty ScienceLtd (KOSDAQ:086710) Shareholders Will Want The ROCE Trajectory To ContinueWhat are the early trends we should look for to identify a stock that could multiply in value over the long term? In a...
Valuation Update With 7 Day Price Move • Dec 16Investor sentiment improves as stock rises 15%After last week's 15% share price gain to ₩9,740, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 7x in the Chemicals industry in South Korea. Total returns to shareholders of 45% over the past three years.
Reported Earnings • Nov 20Third quarter 2024 earnings released: EPS: ₩92.00 (vs ₩13.00 in 3Q 2023)Third quarter 2024 results: EPS: ₩92.00 (up from ₩13.00 in 3Q 2023). Revenue: ₩18.2b (up 19% from 3Q 2023). Net income: ₩1.10b (up ₩943.2m from 3Q 2023). Profit margin: 6.1% (up from 1.1% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 30% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Nov 12Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩9,230, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 8x in the Chemicals industry in South Korea. Total returns to shareholders of 25% over the past three years.
分析記事 • Nov 04Sunjin Beauty ScienceLtd (KOSDAQ:086710) Has A Pretty Healthy Balance SheetWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to ₩10,750, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 4.1% over the past three years.
分析記事 • Aug 04Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) 30% Cheaper Price Remains In Tune With EarningsThe Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) share price has softened a substantial 30% over the previous 30...
Buy Or Sell Opportunity • Aug 02Now 22% undervaluedOver the last 90 days, the stock has risen 38% to ₩12,220. The fair value is estimated to be ₩15,613, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 48% in 2 years. Earnings are forecast to grow by 119% in the next 2 years.
分析記事 • Jul 27Is Sunjin Beauty ScienceLtd (KOSDAQ:086710) Using Too Much Debt?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
分析記事 • Jul 04What Does Sunjin Beauty Science Co.Ltd's (KOSDAQ:086710) Share Price Indicate?Sunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ), might not be a large cap stock, but it received a lot of attention from...
Valuation Update With 7 Day Price Move • Jul 03Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩17,470, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 73% over the past three years.
Buy Or Sell Opportunity • Jul 01Now 25% overvalued after recent price riseOver the last 90 days, the stock has risen 122% to ₩17,860. The fair value is estimated to be ₩14,271, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 48% in 2 years. Earnings are forecast to grow by 119% in the next 2 years.
分析記事 • Jun 19After Leaping 94% Sunjin Beauty Science Co.Ltd (KOSDAQ:086710) Shares Are Not Flying Under The RadarSunjin Beauty Science Co.Ltd ( KOSDAQ:086710 ) shares have continued their recent momentum with a 94% gain in the last...
Buy Or Sell Opportunity • Jun 18Now 22% overvalued after recent price riseOver the last 90 days, the stock has risen 174% to ₩21,250. The fair value is estimated to be ₩17,414, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 25% in a year. Earnings are forecast to grow by 439% in the next year.
Valuation Update With 7 Day Price Move • Jun 14Investor sentiment improves as stock rises 22%After last week's 22% share price gain to ₩22,200, the stock trades at a forward P/E ratio of 8x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 132% over the past three years.
Buy Or Sell Opportunity • Jun 14Now 27% overvalued after recent price riseOver the last 90 days, the stock has risen 190% to ₩22,200. The fair value is estimated to be ₩17,446, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 19% over the last 3 years. Earnings per share has grown by 63%. Revenue is forecast to grow by 25% in a year. Earnings are forecast to grow by 439% in the next year.
分析記事 • Jun 06Sunjin Beauty ScienceLtd (KOSDAQ:086710) Shareholders Will Want The ROCE Trajectory To ContinueIf you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...
New Risk • May 30New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Profit margins are more than 30% lower than last year (8.4% net profit margin).
Valuation Update With 7 Day Price Move • May 29Investor sentiment improves as stock rises 25%After last week's 25% share price gain to ₩15,500, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 9x in the Chemicals industry in South Korea. Total returns to shareholders of 59% over the past three years.
Reported Earnings • May 19First quarter 2024 earnings released: EPS: ₩271 (vs ₩225 in 1Q 2023)First quarter 2024 results: EPS: ₩271 (up from ₩225 in 1Q 2023). Revenue: ₩20.8b (up 2.0% from 1Q 2023). Net income: ₩3.25b (up 20% from 1Q 2023). Profit margin: 16% (up from 13% in 1Q 2023). Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in South Korea. Over the last 3 years on average, earnings per share has increased by 63% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • May 14Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩10,460, the stock trades at a forward P/E ratio of 4x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 11% over the past three years.
分析記事 • Apr 23Does Sunjin Beauty ScienceLtd (KOSDAQ:086710) Have A Healthy Balance Sheet?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Upcoming Dividend • Dec 20Upcoming dividend of ₩20.00 per share at 0.2% yieldEligible shareholders must have bought the stock before 27 December 2023. Payment date: 24 April 2024. Payout ratio is a comfortable 1.2% but the company is not cash flow positive. Trailing yield: 0.2%. Lower than top quartile of South Korean dividend payers (3.5%). Lower than average of industry peers (1.8%).
New Risk • Nov 30New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 31% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (31% accrual ratio). Minor Risk Market cap is less than US$100m (₩91.6b market cap, or US$70.6m).
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₩7,960, the stock trades at a trailing P/E ratio of 4.6x. Average forward P/E is 13x in the Chemicals industry in South Korea. Total returns to shareholders of 29% over the past year.
Valuation Update With 7 Day Price Move • Jun 28Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩10,560, the stock trades at a trailing P/E ratio of 6.1x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 77% over the past year.
Valuation Update With 7 Day Price Move • May 10Investor sentiment improves as stock rises 31%After last week's 31% share price gain to ₩8,520, the stock trades at a trailing P/E ratio of 5.2x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total returns to shareholders of 17% over the past year.
Valuation Update With 7 Day Price Move • Mar 30Investor sentiment improves as stock rises 16%After last week's 16% share price gain to ₩6,950, the stock trades at a trailing P/E ratio of 4.3x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 11% over the past year.
Upcoming Dividend • Dec 21Upcoming dividend of ₩10.00 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 26 April 2023. Payout ratio is a comfortable 6.6% but the company is not cash flow positive. Trailing yield: 0.1%. Lower than top quartile of South Korean dividend payers (3.2%). Lower than average of industry peers (2.4%).
Valuation Update With 7 Day Price Move • Dec 13Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩7,250, the stock trades at a trailing P/E ratio of 47.2x. Average forward P/E is 10x in the Chemicals industry in South Korea. Total returns to shareholders of 4.1% over the past year.
Valuation Update With 7 Day Price Move • Nov 11Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩6,410, the stock trades at a trailing P/E ratio of 43x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 13% over the past year.
Valuation Update With 7 Day Price Move • Sep 27Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩5,210, the stock trades at a trailing P/E ratio of 34.9x. Average forward P/E is 11x in the Chemicals industry in South Korea. Total loss to shareholders of 41% over the past year.
Valuation Update With 7 Day Price Move • Jun 22Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩5,530, the stock trades at a trailing P/E ratio of 39.1x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 43% over the past year.
Buying Opportunity • May 10Now 21% undervalued after recent price dropOver the last 90 days, the stock is down 2.8%. The fair value is estimated to be ₩9,160, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.0% over the last year. Earnings per share has declined by 64%.
Valuation Update With 7 Day Price Move • Mar 04Investor sentiment improved over the past weekAfter last week's 18% share price gain to ₩21,400, the stock trades at a trailing P/E ratio of 50.5x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total returns to shareholders of 5.6% over the past year.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improved over the past weekAfter last week's 17% share price gain to ₩14,850, the stock trades at a trailing P/E ratio of 35x. Average trailing P/E is 16x in the Chemicals industry in South Korea. Total loss to shareholders of 44% over the past year.
Buying Opportunity • Jan 21Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 15%. The fair value is estimated to be ₩17,656, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last year. Earnings per share has declined by 32% over the last year.